![Richard Steinhart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Steinhart
Director of Finance/CFO at BIOXCEL THERAPEUTICS, INC.
Net worth: 11 200 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steven Quay | M | 73 | 16 years | |
Steve O'Loughlin | M | 39 | 9 years | |
Vimal Mehta | M | 63 | 7 years | |
Sean Power | M | 42 | 13 years | |
Peter Mueller | M | 68 | 7 years | |
Shu-Chih Chen | M | 62 | 16 years | |
Sandesh Seth | M | 60 | 12 years | |
Heather Rees | F | 51 | 7 years | |
Delly Behen | F | - | 10 years | |
June Bray | F | 70 | 3 years | |
Avinash Desai | M | - | 4 years | |
Eric van Zanten | M | - | 2 years | |
Jeffrey Chell | M | 70 | 6 years | |
Michal Votruba | M | 58 | 5 years | |
Michael Miller | M | 67 | 2 years | |
Rajiv Patni | M | 55 | 1 years | |
Javier Rodriguez | M | 52 | 3 years | |
Stephen Galli | M | 77 | 13 years | |
Thomas Walker MacAllister | M | - |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | 8 years |
Ajit Shetty | M | 77 | 7 years | |
H. Remmel | M | 72 | 12 years | |
Sandeep Laumas | M | 56 | 7 years | |
Jenna A. Bosco | F | - | 13 years | |
C. Nicholson | M | 69 | 16 years | |
Erik Kopp | M | - | 3 years | |
Monideepa Roy | M | - | 3 years | |
Stephen Dressel | M | - | - | |
Sunitha Lakshminarayanan | F | - | - | |
Jenny Hsieh | F | - | - | |
Richard Graydon | M | - | 2 years | |
Brennan Doyle | M | - | - | |
Lynn M. Bodarky | F | 58 | 1 years | |
Roger Ulrich | M | - |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | 8 years |
Paul Diamond | M | - | 3 years | |
Mary Mei Chen | M | - | 4 years | |
Gary Siegel | M | 66 | 7 years | |
Chetan Lathia | M | - | - | |
Matthew Wiley | M | 52 | 2 years | |
Frank Yocca | M | 68 | 7 years | |
Jonathan Finn | M | 50 | 1 years | |
Vincent O'Neill | M | 55 | 7 years | |
Arezoo Mirad | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Steinhart
- Personal Network